NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Just stop for a moment RK, ask yourself this question.

How could you possibly argue they were planning, in August 2014, to end the trial in late 2018 when they said this in December 2014????

Look at the statement below from Linda Powers in December 2014.

Looking towards 2015, we expect to finish enrollment. I went over the 55 patients. We expect to finish enrollment, in the Phase III trial, hopefully in around September time frame, it depends a little bit on how fast, how many more of the European sites come on. But, we expect to finish about then. And we expect topline results to be about 3 to 5 months after full enrollment. So around the end of next year or slightly after, we expect to be reaching the finish line on that Phase III trial.